Cytokinetics, Incorporated (CYTK)
NASDAQ · Healthcare
Cytokinetics, Incorporated Income Statement 2009–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | |||||||||||||||||
| Revenue | 88.0M | 18.5M | 7.5M | 94.6M | 70.4M | 55.8M | 26.9M | 31.5M | 13.4M | 106.4M | 28.7M | 46.9M | 30.6M | 7.6M | 4.0M | 2.6M | 81.5M |
| Gross Profit | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Profitability | |||||||||||||||||
| Operating Income | -612.3M | -536.2M | -496.2M | -324.2M | -186.3M | -93.9M | -98.9M | -88.9M | -113.4M | 18.7M | -37.4M | -14.8M | -33.9M | -40.5M | -48.0M | -49.6M | 26.1M |
| EBITDA | -602.1M | -526.7M | -484.3M | -318.4M | -184.0M | -92.1M | -97.6M | -87.7M | -111.5M | 19.4M | -36.8M | -14.3M | -33.5M | -39.9M | -46.7M | -47.7M | 28.1M |
| Net Income | -785.0M | -589.5M | -526.2M | -389.0M | -215.3M | -127.3M | -121.7M | -106.3M | -127.8M | 16.5M | -37.5M | -14.6M | -33.7M | -40.4M | -47.9M | -49.3M | 24.5M |
| Per Share Data | |||||||||||||||||
| EPS (diluted) | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding (dil.) | 0M | 0M | 0M | 0M | 0M | 0M | 59M | 55M | 49M | 43M | 39M | 36M | 31M | 24M | 71M | 64M | 58M |
Cytokinetics, Incorporated Income Statement — FAQ
Cytokinetics, Incorporated (CYTK) income statement over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see CYTK's income statement history?
The chart and table above show Cytokinetics, Incorporated's income statement by year and by quarter, including the growth rate.